Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model

Yumi Yokoyama, Jeffrey E. Green, Vikas P. Sukhatme, Sundaram Ramakrishnan

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

A transgenic mouse model was used to evaluate the effect of endostatin treatment on spontaneous tumorigenesis. In this model system, female mice develop multiple mammary adenocarcinomas and male mice develop prostate cancer. Female mice treated with mouse endostatin during a 12-15-week period showed delayed tumor development by 4-6 weeks and significantly decreased tumor burden. Furthermore, endostatin treatment reduced the number of malignant lesions per mouse. In a separate set of experiments, male mice treated with endostatin showed a survival advantage, and their life spans were prolonged by 10.5 weeks over control animals. These data demonstrate that mouse endostatin is effective in delaying spontaneous tumor development and growth.

Original languageEnglish (US)
Pages (from-to)4362-4365
Number of pages4
JournalCancer Research
Volume60
Issue number16
StatePublished - Aug 15 2000
Externally publishedYes

Fingerprint

Endostatins
Transgenic Mice
Carcinogenesis
Adenocarcinoma
Breast
Tumor Burden
Growth and Development
Neoplasms
Prostatic Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model. / Yokoyama, Yumi; Green, Jeffrey E.; Sukhatme, Vikas P.; Ramakrishnan, Sundaram.

In: Cancer Research, Vol. 60, No. 16, 15.08.2000, p. 4362-4365.

Research output: Contribution to journalArticle

Yokoyama, Yumi ; Green, Jeffrey E. ; Sukhatme, Vikas P. ; Ramakrishnan, Sundaram. / Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model. In: Cancer Research. 2000 ; Vol. 60, No. 16. pp. 4362-4365.
@article{ae6c6b1de30a45dabb5723476caf9e54,
title = "Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model",
abstract = "A transgenic mouse model was used to evaluate the effect of endostatin treatment on spontaneous tumorigenesis. In this model system, female mice develop multiple mammary adenocarcinomas and male mice develop prostate cancer. Female mice treated with mouse endostatin during a 12-15-week period showed delayed tumor development by 4-6 weeks and significantly decreased tumor burden. Furthermore, endostatin treatment reduced the number of malignant lesions per mouse. In a separate set of experiments, male mice treated with endostatin showed a survival advantage, and their life spans were prolonged by 10.5 weeks over control animals. These data demonstrate that mouse endostatin is effective in delaying spontaneous tumor development and growth.",
author = "Yumi Yokoyama and Green, {Jeffrey E.} and Sukhatme, {Vikas P.} and Sundaram Ramakrishnan",
year = "2000",
month = "8",
day = "15",
language = "English (US)",
volume = "60",
pages = "4362--4365",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model

AU - Yokoyama, Yumi

AU - Green, Jeffrey E.

AU - Sukhatme, Vikas P.

AU - Ramakrishnan, Sundaram

PY - 2000/8/15

Y1 - 2000/8/15

N2 - A transgenic mouse model was used to evaluate the effect of endostatin treatment on spontaneous tumorigenesis. In this model system, female mice develop multiple mammary adenocarcinomas and male mice develop prostate cancer. Female mice treated with mouse endostatin during a 12-15-week period showed delayed tumor development by 4-6 weeks and significantly decreased tumor burden. Furthermore, endostatin treatment reduced the number of malignant lesions per mouse. In a separate set of experiments, male mice treated with endostatin showed a survival advantage, and their life spans were prolonged by 10.5 weeks over control animals. These data demonstrate that mouse endostatin is effective in delaying spontaneous tumor development and growth.

AB - A transgenic mouse model was used to evaluate the effect of endostatin treatment on spontaneous tumorigenesis. In this model system, female mice develop multiple mammary adenocarcinomas and male mice develop prostate cancer. Female mice treated with mouse endostatin during a 12-15-week period showed delayed tumor development by 4-6 weeks and significantly decreased tumor burden. Furthermore, endostatin treatment reduced the number of malignant lesions per mouse. In a separate set of experiments, male mice treated with endostatin showed a survival advantage, and their life spans were prolonged by 10.5 weeks over control animals. These data demonstrate that mouse endostatin is effective in delaying spontaneous tumor development and growth.

UR - http://www.scopus.com/inward/record.url?scp=0034662624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034662624&partnerID=8YFLogxK

M3 - Article

C2 - 10969778

AN - SCOPUS:0034662624

VL - 60

SP - 4362

EP - 4365

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -